×
Close
註冊
登入
主页
用户
博客
照片
视频
医学图书S馆
医学图书M馆
医学图书D馆
医学术语
群组
活动
用户工具
用户指南
问答
谁看过我
反馈
语言
English
中文
推广
×
Close
CN1699 Our Business - Guide for Agents
分类
Hematology
5667
Global Medical University
5503
Allergy
1827
Anatomy & Morphology
1601
Andrology
414
Anesthesia & Intensive Care
1337
Anesthesiology
5810
Audiology & Speech-Language Pathology
335
Behavioral Sciences
104
Biochemical Research Methods
7365
Biochemistry & Molecular Biology
31252
Biodiversity Conservation
334
Biology
8927
Biophysics
9280
Biotechnology & Applied Microbiology
8815
Cardiac & Cardiovascular Systems
32852
Cardiovascular & Respiratory Systems
1493
Cell & Tissue Engineering
700
Cell Biology
11370
Chemistry, Analytical
4394
Chemistry, Applied
11818
Chemistry, Medicinal
8922
Chemistry, Multidisciplinary
19565
Clinical Immunology & Infectious Disease
456
Clinical Medicine
9104
Clinical Neurology
17188
Clinical Psychology & Psychiatry
1491
Critical Care Medicine
3416
Dentistry, Oral Surgery & Medicine
13936
Dermatology
7771
Developmental Biology
7253
Ecology
645
Education, Scientific Disciplines
2004
Emergency Medicine
4342
Endocrinology, Metabolism & Nutrition
25597
Engineering, Biomedical
3783
Entomology
449
Environmental Medicine & Public Health
4967
Evolutionary Biology
270
Gastroenterology & Hepatology
12636
General & Internal Medicine
7425
Genetics & Heredity
15857
Geriatrics & Gerontology
5231
Gerontology
349
Health Care Sciences & Services
16750
Health Policy & Services
613
Immunology
26782
Infectious Diseases
14579
Integrative & Complementary Medicine
2951
Medical Ethics
1208
Medical Informatics
2351
Medical Laboratory Technology
433
Medicine, General & Internal
46869
Medicine, Legal
534
Medicine, Research & Experimental
19053
Microbiology
24688
Mycology
0
Nanoscience & Nanotechnology
5465
Neuroimaging
1381
Neurology
4778
Neurosciences
42144
Nursing
9874
Nutrition & Dietetics
8156
Obstetrics & Gynecology
8650
Oncology
55183
Ophthalmology
10335
Optics
4523
Orthopedics
12116
Orthopedics, Rehabilitation & Sports Medicine
1857
Otolaryngology
1573
Otorhinolaryngology
5130
Parasitology
1078
Pathology
5157
Pediatrics
22579
Peripheral Vascular Disease
4860
Pharmacology & Pharmacy
36984
Pharmacology/Toxicology
13056
Physiology
9339
Polymer Science
599
Primary Health Care
853
Psychiatry
20885
Psychology
5332
Psychology, Applied
93
Psychology, Biological
352
Psychology, Clinical
829
Psychology, Developmental
222
Psychology, Educational
137
Psychology, Experimental
133
Psychology, Mathematical
0
Psychology, Multidisciplinary
1624
Psychology, Psychoanalysis
41
Psychology, Social
116
Public Health & Health Care Science
2308
Public, Environmental & Occupational Health
28703
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
12982
Radiology, Nuclear Medicine & Medical Imaging
8110
Rehabilitation
3078
Remote Sensing
0
Reproductive Biology
3028
Reproductive Medicine
1242
Research/Laboratory Medicine & Medical Technology
4176
Respiratory System
7606
Rheumatology
6244
Social Sciences, Biomedical
1238
Substance Abuse
2815
Surgery
35654
Toxicology
4430
Transplantation
933
Tropical Medicine
314
Urology & Nephrology
13707
Veterinary Sciences
35
Virology
2493
Zoology
0
渠道
THERAPEUTIC ADVANCES IN HEMATOLOGY
35
Hematology\Oncology
3
Medrxiv - Hematology
184
AMERICAN JOURNAL OF HEMATOLOGY
248
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
20
BLOOD CANCER JOURNAL
509
BRITISH JOURNAL OF HAEMATOLOGY
460
CIRCULATION RESEARCH
383
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
588
HAEMOPHILIA
143
JOURNAL OF CLINICAL APHERESIS
57
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
258
LANCET HAEMATOLOGY
29
ACTA HAEMATOLOGICA
159
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
141
BLOOD COAGULATION & FIBRINOLYSIS
67
BLOOD PURIFICATION
188
CURRENT OPINION IN HEMATOLOGY
42
EUROPEAN JOURNAL OF HAEMATOLOGY
95
EXPERIMENTAL HEMATOLOGY & ONCOLOGY
253
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
231
HAMOSTASEOLOGIE
190
ASIAN JOURNAL OF TRANSFUSION SCIENCE
20
EGYPTIAN JOURNAL OF HAEMATOLOGY
35
HEMASPHERE
404
HEMATOLOGY REPORTS
17
IRAQI JOURNAL OF HEMATOLOGY
88
CURRENT HEMATOLOGIC MALIGNANCY REPORTS
108
INTERNATIONAL JOURNAL OF HEMATOLOGY
589
JOURNAL OF HEMATOPATHOLOGY
123
SCI时时刷
search
全部
推荐
+
A 10-fold and greater increase in D-dimer at admission in COVID-19 patients is highly predictive of pulmonary embolism in a retrospective cohort study
Background:COVID-19 patients present with both elevated D-dimer and a higher incidence of pulmonary embolism (PE). This si...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Prophylactic management of patients with von Willebrand disease
Von Willebrand disease, the most common inherited bleeding disorder that affects both males and females, is due to quantit...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study
Introduction:Treatment-refractory, acute graft-versus-host disease (GvHD) of the lower gastrointestinal tract (GI) after a...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias
Mitapivat (AG-348) is a novel, first-in-class oral small molecule allosteric activator of the pyruvate kinase enzyme. Mita...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Hepatic venoocclusive disease/sinusoidal obstruction syndrome with normal portal vein flow mimicking aggravated chronic hepatic GVHD following inotuzumab ozogamicin salvage therapy: a case report of pathologic-radiologic discrepancy
Inotuzumab ozogamicin (INO) showed improved treatment outcomes for relapsed or refractory B-cell precursor acute lymphobla...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin
Background:Allogeneic stem cell transplantation (alloSCT) offers cure chance for various hematologic malignancies, but gra...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States
Introduction:The choice of BCR-ABL1 tyrosine kinase inhibitors (TKI) for the first line of therapy (LOT) for chronic-phase...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis
Primary systemic immunoglobulin light chain (AL) amyloidosis is caused by a plasma cell clone of, usually low, malignant p...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Bortezomib in autoimmune hemolytic anemia and beyond
Bortezomib is a first-in-class, potent, selective and reversible proteasome inhibitor approved for the treatment of multip...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphoma
1. Rodriguez-Abreu, D, Bordoni, A, Zucca, E. Epidemiology of hematological malignancies. Ann Oncol 2007; 18(Suppl. 1): i3–...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations
Introduction:In patients with primary immune thrombocytopenia (ITP), a short course of steroids is routinely given as firs...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Current and emerging treatment options in primary mediastinal B-cell lymphoma
Previously considered a subtype of diffuse large B-cell lymphoma (DLBCL), primary mediastinal B-cell lymphoma (PMBCL) is n...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Case series: MRD negativity assessment using 11C-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myeloma
Complete response (CR) is an important favorable factor for survival in multiple myeloma (MM). However, CR patients contin...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Design of an international investigator-initiated study on MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A (MOTIVATE)
Background:Inhibitor development is the most serious treatment-related complication of replacement coagulation factor VIII...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome
Introduction:Donor lymphocyte infusion (DLI) is one of the effective options for post-transplant disease control of myelod...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Emicizumab in acquired haemophilia A: about two clinical cases and literature review
Acquired haemophilia A (AHA) is a rare and severe haemorrhagic autoimmune disease caused by autoantibodies directed agains...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia
The pathological increase of clonal IgM in Waldenström macroglobulinemia can be associated with acquired von Willebrand sy...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia
In recent years, one of the most successful advances in treating acute myeloid leukaemia (AML) has been the combination of...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Challenges of biological monitoring in a hemophilia A patient without inhibitors on emicizumab undergoing major orthopedic surgery: a case report
A man with severe hemophilia A (HA) without factor VIII (FVIII) inhibitors was admitted for total arthroplasty of his elbo...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Addition of chemotherapy to nivolumab after PD-1 inhibitor failure as bridge to allogeneic stem cell transplantation in classical Hodgkin’s lymphoma: report on three cases and literature review
The poor prognosis of refractory or relapsed (R/R) classical Hodgkin’s lymphoma (cHL) after autologous stem cell transplan...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study
Background:Daratumumab (Dara) is generally well tolerated, but is associated with increased risk of infection.Methods:We i...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Clinical features of DDX41 mutation-related diseases: a systematic review with individual patient data
Background:DDX41 serves as a DNA sensor in innate immunity and mutated DDX41 is pathogenic, mainly for myeloid neoplasms.M...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
The use of tafasitamab in diffuse large B-cell lymphoma
Patients who relapse or are refractory after first-line therapy for diffuse large B-cell lymphoma (DLBCL) frequently have ...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Features of indeterminate results of QuantiFERON-TB Gold In-Tube test in patients with haematological malignancies
Background and aims:The application of QuantiFERON-TB Gold in-Tube (QFT-GIT) in patients with haematological malignancies ...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma
Aims:This study quantifies the value of survival gains attributable to novel treatments approved since 2003 for United Sta...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
CORRIGENDUM to “Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?”
Access to society journal content varies across our titles. If you have access to a journal via a society or association ...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Treosulfan-based conditioning for inborn errors of immunity
Inborn errors of immunity (IEI) are inherited disorders that lead to defects in the development and/or function of the imm...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications
Diffuse large B-cell lymphoma (DLBCL) represents a group of tumors characterized by substantial heterogeneity in terms of ...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
The role of tazemetostat in relapsed/refractory follicular lymphoma
Large strides have been made in the treatment of follicular lymphoma (FL) over the last few years. Although the majority o...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
The role of axicabtagene ciloleucel as a treatment option for patients with follicular/marginal zone lymphoma
Chimeric antigen receptor (CAR) T-cell therapy with axicabtagene ciloleucel (axi-cel) continues to make its way in the tre...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
阅读更多
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin